ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

HDII Hypertension Diagnositc Inc (CE)

0.000001
0.00 (0.00%)
31 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Hypertension Diagnositc Inc (CE) USOTC:HDII OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.000001 0.00 01:00:00

- Statement of Changes in Beneficial Ownership (4)

14/02/2012 10:20pm

Edgar (US Regulatory)


FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

BRIMMER KENNETH WILLIAM
2. Issuer Name and Ticker or Trading Symbol

HYPERTENSION DIAGNOSTICS INC /MN [ HDII ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      __ X __ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
CEO and CFO
(Last)          (First)          (Middle)

10275 WAYZATA BLVD. SUITE 310
3. Date of Earliest Transaction (MM/DD/YYYY)

2/10/2012
(Street)

MINNETONKA, MN 55305
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock                  6000   I   By Spouse's IRA  
Common Stock   2/10/2012     A (1)    9062907   A $ 0   9253899   D    
Common Stock   2/10/2012     G   V 500000   D $ 0   8753899   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock Warrant   $0.3                    8/28/2003   9/30/2012   Common Stock   99745     99745   D    
Series A Preferred Stock Warrant   $0.14                    8/28/2003   12/31/2012   Series A Preferred Stock   6272     6272   D    
Series A Preferred Stock   $1.68                      (2)   (3) Common Stock   107520     8960   D    
Options   (6) $0.43                      (2) 12/9/2012   Common Stock   4000     4000   D    
Options   (6) $0.2                      (2) 12/17/2013   Common Stock   300000     300000   D    
Stock Options   (6) $0.16                    11/28/2009   11/27/2016   Common Stock   450000     450000   D    
Stock Options   (6) $0.11                      (4) 12/17/2019   Common Stock   225000     225000   D    
Stock Options   (6) $0.1                      (5) 12/16/2020   Common Stock   225000     225000   D    

Explanation of Responses:
( 1)  Grant of restricted stock, which restrictions lapse as of 2/10/2015.
( 2)  Immediately exercisable.
( 3)  No expiration date.
( 4)  56,250 shares vest on each of 3/17/2010, 6/17/2010, 9/17/2010 and 12/17/2010.
( 5)  56,250 shares vest on each of 3/31/2011, 6/30/2011, 9/30/2011 and 12/31/2011.
( 6)  Right to buy.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
BRIMMER KENNETH WILLIAM
10275 WAYZATA BLVD. SUITE 310
MINNETONKA, MN 55305
X X CEO and CFO

Signatures
/s/ Kenneth W. Brimmer 2/14/2012
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

1 Year Hypertension Diagnositc (CE) Chart

1 Year Hypertension Diagnositc (CE) Chart

1 Month Hypertension Diagnositc (CE) Chart

1 Month Hypertension Diagnositc (CE) Chart